- Home
- JRI
JRI
Nuveen Real Asset Income and Growth Fund of Beneficial Interest
as 11-15-2024 4:00pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 68.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $9.70 - $12.12 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Nuveen Real Asset Income and Growth Fund of Beneficial Interest News
JRI Breaking Stock News: Dive into JRI Ticker-Specific Updates for Smart Investing
Business Wire
6 months ago
Nuveen Closed-End Funds Announce Leading Independent Proxy Advisory Firm, Glass Lewis, Fully Supports Nuveen’s Board Nominees
PR Newswire
7 months ago
Nuveen Announces Closing of $1.25 Billion Senior Notes Offering
Business Wire
9 months ago
Nuveen Real Asset Income and Growth Fund Announces Update to Portfolio Management Team
Insider Monkey
10 months ago
30 Best Cardiology Hospitals In the US
Simply Wall St.
10 months ago
Should You Investigate Universal Technical Institute, Inc. (NYSE:UTI) At US$15.19?
Simply Wall St.
10 months ago
Liberty Energy Inc. (NYSE:LBRT) Annual Results: Here's What Analysts Are Forecasting For This Year
Barrons.com
10 months ago
Manufacturing Activity in Central U.S. Drops Sharply at Start of Year
Reuters
10 months ago
UPDATE 3-SEC probes B. Riley deals with client tied to failed hedge fund - Bloomberg News
Compare JRI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.